Your browser doesn't support javascript.
loading
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.
Wheatley, Adam K; Juno, Jennifer A; Wang, Jing J; Selva, Kevin J; Reynaldi, Arnold; Tan, Hyon-Xhi; Lee, Wen Shi; Wragg, Kathleen M; Kelly, Hannah G; Esterbauer, Robyn; Davis, Samantha K; Kent, Helen E; Mordant, Francesca L; Schlub, Timothy E; Gordon, David L; Khoury, David S; Subbarao, Kanta; Cromer, Deborah; Gordon, Tom P; Chung, Amy W; Davenport, Miles P; Kent, Stephen J.
Afiliación
  • Wheatley AK; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Juno JA; Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC, Australia.
  • Wang JJ; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Selva KJ; Department of Immunology, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
  • Reynaldi A; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Tan HX; Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
  • Lee WS; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Wragg KM; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Kelly HG; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Esterbauer R; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Davis SK; Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC, Australia.
  • Kent HE; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Mordant FL; Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC, Australia.
  • Schlub TE; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Gordon DL; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Khoury DS; Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia.
  • Subbarao K; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Cromer D; Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
  • Gordon TP; Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Chung AW; Department of Microbiology and Infectious Diseases, Flinders University and SA Pathology, Flinders Medical Centre, Adelaide, SA, Australia.
  • Davenport MP; Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
  • Kent SJ; Department of Microbiology and Immunology, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Nat Commun ; 12(1): 1162, 2021 02 19.
Article en En | MEDLINE | ID: mdl-33608522
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 / Inmunidad Celular / Memoria Inmunológica / Anticuerpos Antivirales / Formación de Anticuerpos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 / Inmunidad Celular / Memoria Inmunológica / Anticuerpos Antivirales / Formación de Anticuerpos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article